Dr. Rzigalinski is a professor of pharmacology at the Via College of Osteopathic Medicine in Blacksburg, VA. She also holds joint appointments in the Virginia Tech/Wake Forest School of Biomedical Engineering and the Virginia-Maryland Regional College of Veterinary Medicine. She received her BS in biology, cum laude, from Rutgers, an MS in biochemistry and toxicology from New York University, and a PhD in biochemistry and pharmacology from Eastern Virginia Medical School and Old Dominion University. Dr. Rzigalinski is recognized for her work in neurodegenerative disease, nanomedicine and the future of “nanopharmaceuticals.” She has served on numerous national and international committees, review panels and editorial boards. To quote the Founder of Nanotechnology, physicist Richard Feynman, “At the atomic levels, we have new kinds of forces and new kinds of possibilities, new kinds of effects….” whose biological actions are the subject of the work in the Rzigalinski lab. Her current research focuses on the use of nanoparticle constructs in the treatment of neurodegenerative disease, with a focus on Parkinson’s disease.